AI for Diabetic Retinopathy

Book free trial to see how AI can detect DR and 70+ other pathologies/biomarkers

Book Intro

AI Diabetic Retinopathy screening for OCT scans. Detect the subtlest and earliest signs of the pathology before they become clinically visible.

Altris AI, AI for OCT scan analysis, provides:

Quantitive analysis of DR biomarkers in terms of area and volume
Rapid analysis with uncompromised accuracy: swift detection and localization of pathological changes.
Clinical workflow optimization: color-coded visualization of every DR biomarker.
Progression analysis: monitoring the results of the Diabetic Retinopathy treatment objectively.

Platform overview

Only practical features for eye care specialists and clinical research

GDPR compliant (all data is encrypted), CE-certified, and FDA- cleared (510k).

William C. Fruchtman, Optometry Owner

I was really excited to find Altris AI to bolster my skills identifying certain macular diseases. It's a great program and has guided me in the diagnosis of complex cases.

3 Oct, 2024

Scott Sedlacek Optometry Owner

Altris AI identified and described pathology that I could not. Early detection changes the treatment from doing nothing to something. Also, Altris AI described something that I thought was worse than it was. Saved me from over-referring. Patients love to see the color-coded images which help as an educational tool and get buy-in on the treatment plan which helps compliance.

1 Feb, 2024

Richard Clare Optometry Owner

We are adding a new OCT to one of our practices and may benefit from some extra support with AI to speed up the interpretation of results and assist the busy Optometry team.

Dec 7, 2023

Make informed decisions based on objective insights.
Leverage the power of longitudinal data analysis for AI DR screening.

Add OCT examinations from different visits to assess the effectiveness of treatment

Detect: see all the biomarkers of Diabetic Retinopathy with the help of color-coding

Identify: explore DR biomarkers of your choice in terms of area, volume

Track: with Progression Tracking see how DR biomarkers transform over time quantitively

How Altris AI works?

And what's the value of using Artificial intelligence for Diabetic Retinopathy

What is Altris AI?

Expert Tool: Altris AI is a web platform created by a team of retina experts led by the PhD in Ophthalmology

Security: It is FDA-cleared, CE-certified, GDPR, HIPAA-compliant

Accessibility: Altris AI is vendor-neutral, we work with all OCT providers

Intuitiveness: It is used by 500+ eye care businesses around the world

AI for Diabetic Retinopathy Screening reaches a new level with Altris AI.

Formats

DICOM format will help you to extract maximum information. However, the system works with all
data formats, such as jpg, and png

OCT equipment

Altris AI is vendor-neutral. We work with all the OCT equipment producers

OCT reports

We create comprehensible OCT reports for patients and doctors

For Clinical Research

What you get with Altris AI:

Accelerate ophthalmic drug trial with AI
Detect DR and its biomarkers ( +70 retinal pathologies and biomarkers) with AI
Track the progression of biomarkers to assess drug efficiency
Enroll the right patients based on fast biomarkers detection
Reduce costs associated with manual scan review with automated analysis
Reduce human made errors to the minimum

For Eye Care

We support you through the whole way

14 Days of Free Trial to see the value
Support during the whole trial period
Early glaucoma assessment module access
CE-certified, GDPR, HIPAA compliant, FDA clearance
Integration support with any EHR, EMR system.
Cloud data storage/on premises possible
Access to the whole functional during trial